Inpatient and White Paper - Pharmacist Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Inpatient

White Paper

Does the Drug Shortage White Paper Fall Short?

FDA Law Blog: Biosimilars

APRIL 8, 2024

Department of Health and Human Services (HHS) recently published a White Paper on Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States —with input from several HHS stakeholders, including FDA, CMS, and the Administration for Strategic Preparedness and Response. By Kalie E.

Inpatient

Inpatient Hospitals Dosage Controlled Substances

How early planning leads to successful market access and drug launch in Europe

Pharmaceutical Technology

FEBRUARY 7, 2023

In addition, reimbursement schemes in European countries differ considerably between the outpatient and inpatient sectors. Almost all countries have full coverage for inpatient medicines, however, drugs in the ambulatory setting often require co-payment.

Insurance Coverage and Processing

Insurance Coverage and Processing Inpatient Drug Pricing Packaging

Does the Drug Shortage White Paper Fall Short?

How early planning leads to successful market access and drug launch in Europe

Stay Connected